RFP Amendment 2.doc

NIAID-DMID-NIHAI2010107

Amendment #2 (Question & Answer)

This Amendment provides a question submitted by potential offerors and the response provided by the NIAID. The response is offered for information only and does not modify or become part of this solicitation. This Amendment will be updated at least weekly to add any further questions and their related responses. All potential offerors are advised to refer back to this Amendment for additional Q&A.

“MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR THE DEVELOPMENT OF VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASE”

Contracting Officer

OA/DEA/NIAID/NIH/DHHS

6700-B Rockledge Drive, Room 3214, Bethesda, Maryland 20892-7612

Nicole Gordon, Contract Specialist

Please also cc:

andersondj@niaid.nih.gov Deborah Anderson, Team Lead

Offerors must acknowledge receipt of the final posting of Amendment #2 on each copy of the proposal submitted. Failure to receive your acknowledgment of this Amendment may result in the rejection of your proposal.

The hour and date specified for receipt of proposals HAS NOT been extended.

Deadline for Receipt of Questions: August 15, 2011

THE FOLLOWING PAGES PROVIDE AN ANSWER CONCERNING AN INQUIRY WE HAVE RECEIVED FOR THE ABOVE NUMBERED ACQUISITION:

Question 1 Attachment 4 (page 21) Sample Task Order 3:

Delete:

1. Evaluate the provided viral/ cell line, produce the requisite banks, and provide appropriate documentation including Certificate of Analysis.

Replace with:

1. Perform work using the available working banks and provide appropriate documentation including Certificates of Analysis.

NIH-NIAID- DMID-NIHAI2010107

Amendment #2 (Q&A)